Drotrecogin Alfa (Activated) in Septic Shock

被引：0
|
作者：
Hollander, Judd E. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：968 / 968
页数：1
相关论文
共 50 条
  • [31] Drotrecogin alfa (activated) in severe sepsis
    Poole, Daniele
    Rossi, Carlotta
    Addis, Antonio
    Livigni, Sergio
    Bertolini, Guido
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 107 - 108
  • [32] Management challenge with drotrecogin alfa (activated)
    Vanscoy, GJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 : S23 - S27
  • [33] Drotrecogin alfa (activated): is there room for improvement?
    Cunningham, Kath
    Jankovic, Zorica
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (11) : 952 - 952
  • [34] The rise and fall of drotrecogin alfa (activated)
    Vincent, Jean-Louis
    LANCET INFECTIOUS DISEASES, 2012, 12 (09): : 649 - 651
  • [35] Smart Identifies Dichotomous Drotrecogin Alfa Activated Treatment Effects on Mortality in Prowess Shock
    Kelter, David
    Slotman, Gus J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S296 - S296
  • [36] Introduction: severe sepsis and drotrecogin alfa (activated)
    Artigas, Antonio
    Martin, Claude D.
    CRITICAL CARE, 2007, 11 (Suppl 5)
  • [37] Drotrecogin alfa (activated) in severe sepsis Reply
    Kalil, Andre C.
    LaRosa, Steven P.
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 110 - 111
  • [38] Drotrecogin alfa (activated): Surviving sepsis by chance
    Levi, Marcel
    Levy, Mitchell
    Williams, Mark D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (06) : 669 - 670
  • [39] Drotrecogin Alfa (Activated)A Viewpoint by Marcel Levi
    Marcel Levi
    Drugs, 2002, 62 : 631 - 631
  • [40] Drotrecogin alfa (activated): the treatment for severe sepsis?
    Vincent, Jean-Louis
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1763 - 1777
12345